Category: ENTIS News

Members of the ENTIS and OTIS Scientific Committees, with with contributions from Michael Ceulemans (KU Leuven, Belgium) PhD student Erika Gram (University of Southern Denmark, Denmark), have published a clinical perspective focussing on the the strengths and limitations of the published literature on the effect of maternal acetaminophen use in pregnancy on the child’s risk of developing attention-deficit and hyperactivity […]

» Read more

A commentary from the ENTIS Scientific Committee has been published in the journal of Pharmacoepidemiology and Drug Safety. Here the members of the committee discuss the recent regulatory recommendations regarding paternal valproate and infant neurodevelopment, and the requirement for data transparency. Read the open access commentary here.

» Read more

ENTIS and OTIS have published an opinion article in Birth Defects Research which argues that the underlying scientific data do not convincingly substantiate the paternal valproate exposure risks to children. Read the full statement here. Photo by Kaitlyn Baker on Unsplash

» Read more

Registration details here

» Read more

The organisers of the 2024 ENTIS-OTIS conference, being held in Nyborg, Denmark (September 12-15th, 2024), have launched the conference website.

» Read more

Prospective delegates are invited to submit research abstracts for the Joint ENTIS-OTIS Meeting which will be held in Nyborg, Denmark from the 12th to 15th September. The abstract submission deadline is 28th March 2024, and authors will be notified of acceptance by 26th April 2024. Please see here for the abstract submission template and instructions for authors. More information about […]

» Read more